BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 27648962)

  • 41. Inactivation of the APC gene is constant in adrenocortical tumors from patients with familial adenomatous polyposis but not frequent in sporadic adrenocortical cancers.
    Gaujoux S; Pinson S; Gimenez-Roqueplo AP; Amar L; Ragazzon B; Launay P; Meatchi T; Libé R; Bertagna X; Audebourg A; Zucman-Rossi J; Tissier F; Bertherat J
    Clin Cancer Res; 2010 Nov; 16(21):5133-41. PubMed ID: 20978149
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone-producing adenomas.
    Taguchi R; Yamada M; Nakajima Y; Satoh T; Hashimoto K; Shibusawa N; Ozawa A; Okada S; Rokutanda N; Takata D; Koibuchi Y; Horiguchi J; Oyama T; Takeyoshi I; Mori M
    J Clin Endocrinol Metab; 2012 Apr; 97(4):1311-9. PubMed ID: 22278422
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Primary aldosteronism caused by a pI157S somatic
    Gomez-Sanchez CE; van Rooyen D; Rainey WE; Nanba K; Blinder AR; Baliga R
    Front Endocrinol (Lausanne); 2022; 13():921449. PubMed ID: 36051386
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Meta-Analysis of Somatic KCNJ5 K(+) Channel Mutations In 1636 Patients With an Aldosterone-Producing Adenoma.
    Lenzini L; Rossitto G; Maiolino G; Letizia C; Funder JW; Rossi GP
    J Clin Endocrinol Metab; 2015 Aug; 100(8):E1089-95. PubMed ID: 26066531
    [TBL] [Abstract][Full Text] [Related]  

  • 45. a Novel Y152C KCNJ5 mutation responsible for familial hyperaldosteronism type III.
    Monticone S; Hattangady NG; Penton D; Isales CM; Edwards MA; Williams TA; Sterner C; Warth R; Mulatero P; Rainey WE
    J Clin Endocrinol Metab; 2013 Nov; 98(11):E1861-5. PubMed ID: 24037882
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Case Report: Nodule Development From Subcapsular Aldosterone-Producing Cell Clusters Causes Hyperaldosteronism.
    Nishimoto K; Seki T; Kurihara I; Yokota K; Omura M; Nishikawa T; Shibata H; Kosaka T; Oya M; Suematsu M; Mukai K
    J Clin Endocrinol Metab; 2016 Jan; 101(1):6-9. PubMed ID: 26580238
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Novel Somatic Deletion Mutation of ATP2B3 in Aldosterone-Producing Adenoma.
    Murakami M; Yoshimoto T; Minami I; Bouchi R; Tsuchiya K; Hashimoto K; Izumiyama H; Fujii Y; Endo T; Akashi T; Nishimoto K; Mukai K; Kihara K; Ogawa Y
    Endocr Pathol; 2015 Dec; 26(4):328-33. PubMed ID: 26481629
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Histological Characterization of Aldosterone-producing Adrenocortical Adenomas with Different Somatic Mutations.
    Ono Y; Yamazaki Y; Omata K; Else T; Tomlins SA; Rhayem Y; Williams TA; Reincke M; Carling T; Monticone S; Mulatero P; Beuschlein F; Ito S; Satoh F; Rainey WE; Sasano H
    J Clin Endocrinol Metab; 2020 Mar; 105(3):e282-9. PubMed ID: 31789380
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of KCNJ5 mutations on gene expression in aldosterone-producing adenomas and adrenocortical cells.
    Monticone S; Hattangady NG; Nishimoto K; Mantero F; Rubin B; Cicala MV; Pezzani R; Auchus RJ; Ghayee HK; Shibata H; Kurihara I; Williams TA; Giri JG; Bollag RJ; Edwards MA; Isales CM; Rainey WE
    J Clin Endocrinol Metab; 2012 Aug; 97(8):E1567-72. PubMed ID: 22628608
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Aldosterone-Regulating Receptors and Aldosterone-Driver Somatic Mutations.
    Lim JS; Plaska SW; Rege J; Rainey WE; Turcu AF
    Front Endocrinol (Lausanne); 2021; 12():644382. PubMed ID: 33796077
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phenotype-genotype correlation in aldosterone-producing adenomas characterized by intracellular cholesterol metabolism.
    Harashima S; Yamazaki Y; Motomura N; Ono Y; Omata K; Tezuka Y; Morimoto R; Nakamura Y; Satoh F; Suzuki H; Kwon GE; Choi MH; Sasano H
    J Steroid Biochem Mol Biol; 2022 Jul; 221():106116. PubMed ID: 35533918
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Predictive value of preoperative tests in discriminating bilateral adrenal hyperplasia from an aldosterone-producing adrenal adenoma.
    Phillips JL; Walther MM; Pezzullo JC; Rayford W; Choyke PL; Berman AA; Linehan WM; Doppman JL; Gill JR
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4526-33. PubMed ID: 11134103
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Novel somatic mutations and distinct molecular signature in aldosterone-producing adenomas.
    Åkerström T; Willenberg HS; Cupisti K; Ip J; Backman S; Moser A; Maharjan R; Robinson B; Iwen KA; Dralle H; D Volpe C; Bäckdahl M; Botling J; Stålberg P; Westin G; Walz MK; Lehnert H; Sidhu S; Zedenius J; Björklund P; Hellman P
    Endocr Relat Cancer; 2015 Oct; 22(5):735-44. PubMed ID: 26285814
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetic disorders in primary aldosteronism-familial and somatic.
    Funder JW
    J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt A):154-157. PubMed ID: 27013018
    [TBL] [Abstract][Full Text] [Related]  

  • 55.
    Chang YY; Tsai CH; Peng SY; Chen ZW; Chang CC; Lee BC; Liao CW; Pan CT; Chen YL; Lin LC; Chang YR; Peng KY; Chou CH; Wu VC; Hung CS; Lin YH;
    Hypertension; 2021 Jan; 77(1):114-125. PubMed ID: 33249859
    [TBL] [Abstract][Full Text] [Related]  

  • 56. NEFM (Neurofilament Medium) Polypeptide, a Marker for Zona Glomerulosa Cells in Human Adrenal, Inhibits D1R (Dopamine D1 Receptor)-Mediated Secretion of Aldosterone.
    Maniero C; Garg S; Zhao W; Johnson TI; Zhou J; Gurnell M; Brown MJ
    Hypertension; 2017 Aug; 70(2):357-364. PubMed ID: 28584012
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Primary aldosteronism in a patient with familial adenomatous polyposis.
    Alexander GL; Thompson GB; Schwartz DA
    Mayo Clin Proc; 2000 Jun; 75(6):636-7. PubMed ID: 10852426
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genetics of primary aldosteronism.
    Funder JW
    Front Horm Res; 2014; 43():70-8. PubMed ID: 24943299
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative Genomics and Transcriptome Profiling in Primary Aldosteronism.
    Aristizabal Prada ET; Castellano I; Sušnik E; Yang Y; Meyer LS; Tetti M; Beuschlein F; Reincke M; Williams TA
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29642543
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cardiovascular and metabolic characters of
    Chang YY; Lee BC; Chen ZW; Tsai CH; Chang CC; Liao CW; Pan CT; Peng KY; Chou CH; Lu CC; Wu VC; Hung CS; Lin YH;
    Front Endocrinol (Lausanne); 2023; 14():1061704. PubMed ID: 36950676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.